Expanding Segmentation in the Sickle Cell Disease Market Segment The Sickle Cell Disease Market segment breakdown underscores diverse treatment approaches shaped by product type, therapy, and regional focus. The market is primarily segmented into pharmaceuticals, gene therapy, and bone marrow transplants. Pharmaceutical interventions, such as hydroxyurea and voxelotor, continue to dominate due to accessibility and affordability. However, the gene therapy...